Topinka J, Binkova B, Schwarz L R, Wolff T
Regional Hygiene Institute of Central Bohemia, Praha, Czech Republic.
Carcinogenesis. 1996 Jan;17(1):167-9. doi: 10.1093/carcin/17.1.167.
We have recently shown that cyproterone acetate (CPA), an active component of some antiandrogenic drugs, induces the formation of DNA adducts detectable by the 32P-DNA postlabelling technique in rat liver. The postlabelling technique, however, does not provide evidence for the chemical nature of the adducts observed. To ascertain whether the CPA-induced adducts do contain CPA, we have incubated tritiated CPA with cultured hepatocytes from female rats, digested the DNA to 3'-monophosphonucleosides, extracted the DNA adducts formed into butanol and phosphorylated the adducts in the extract with unlabelled ATP. One major and one minor 3H-labelled adduct spot were detectable on the TLC chromatograms. The spots appeared at positions identical to those observed in the 32P-postlabelling experiments with unlabelled CPA. Furthermore, the ratio of 3H activity for the major versus the minor adduct spot was 11.9 +/- 1.8, which agreed with the corresponding ratio for the 32P activities, which was 13.2 +/- 3.5. These findings indicate that the CPA-induced DNA adducts, which we have previously detected by 32P-postlabelling do contain CPA or CPA metabolites.
我们最近发现,某些抗雄激素药物的活性成分醋酸环丙孕酮(CPA)可诱导大鼠肝脏中形成能用³²P-DNA后标记技术检测到的DNA加合物。然而,后标记技术并未为所观察到的加合物的化学性质提供证据。为确定CPA诱导的加合物是否确实含有CPA,我们将氚标记的CPA与雌性大鼠的培养肝细胞一起孵育,将DNA消化成3'-单磷酸核苷,将形成的DNA加合物萃取到丁醇中,并用未标记的ATP将萃取物中的加合物磷酸化。在薄层色谱图上可检测到一个主要的和一个次要的³H标记加合物斑点。这些斑点出现的位置与用未标记的CPA进行³²P后标记实验中观察到的位置相同。此外,主要加合物斑点与次要加合物斑点的³H活性比为11.9±1.8,这与³²P活性的相应比值13.2±3.5相符。这些发现表明,我们之前通过³²P后标记检测到的CPA诱导的DNA加合物确实含有CPA或CPA代谢物。